| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > The Reality of Marketing Conflict |
|
Digg It - The Reality of Marketing Conflict
Rhetoric aside, it’s clear that marketing is entering a new era, an era that will make th According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e sixties and seventies look like a Sunday school picnic. Competition is getting brutal. ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in The name of the game has become “taking business away from somebody else.” As companies lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. xperiment with different ways to increase sales, they are turning more and more to warfar here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e strategies in general. But aggressiveness alone is not the mark of a good military str d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro tegy. Especially aggressiveness as represented by the “more” school of management. More p ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc roducts, more sales people, more advertising, more hard work. Especially more hard work. easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi Somehow we feel better about success if we have to work hard to achieve it. So we schedul nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e more meetings, more reports, and more memos, more management reviews. Yet military his and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ory teaches the reverse. A single-minded commitment to winning the battle on effort alone ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi usually dissolves into defeat. From the trenches of World War I to the streets of Stalin ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a grad in World War II, the military commander that lets his armies get bogged down in a ha dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d-to-hand slugging match is usually defeated. The dogged determination of Xerox to make cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin it in the office automation market is not a sign of future success. It’s a mark of futili tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen y. Much better are quick, lightning like strokes that depend more on timing than muscle. t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel (What the Germans call blitzkrieg.) Not that muscle, or the principle of force, is not i ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust portant. Far from it. But unless an attack is properly planned, you throw away your advan y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products tage if you let the battle degenerate into a war of attrition. Whenever you hear your co . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de mander say “We have to redouble our efforts,” you know you’re listening to a loser talk. elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip The lights don’t need to burn late in places like Armonk. IBM wins by smarter, not longer tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:The Fear Factor in Russian Business Startups 10 Totally Dumb Business Ideas That Made Someone Rich How To Hand Out Promotional Products
|